Clinical

Dataset Information

0

A phase III, randomized, controlled trial on the benefits of adjuvant chemotherapy after resection of oligometastatic foci in patients after primary colorectal cancer radical resection


ABSTRACT: Interventions: group with adjuvent chemotherapy:adjuvent chemotherapy;non-adjuvent chemotherapy:Observation and follow-up Primary outcome(s): 3-year disease-free survival Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2696858 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC8738893 | biostudies-literature
| S-EPMC10774701 | biostudies-literature
| S-EPMC8027112 | biostudies-literature
| S-EPMC7060852 | biostudies-literature